03.07.2020 | Letter to the Editor
Venetoclax plus cytochrome P450 inhibitors without ramp-up strategy led to low risk of tumor lysis syndrome in acute myeloid leukemia
Erschienen in: Annals of Hematology | Ausgabe 9/2020
Einloggen, um Zugang zu erhalten